1. Home
  2. SUIG vs SEER Comparison

SUIG vs SEER Comparison

Compare SUIG & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SUIG

Sui Group Holdings Limited

N/A

Current Price

$1.21

Market Cap

114.4M

Sector

Finance

ML Signal

N/A

Logo Seer Inc.

SEER

Seer Inc.

HOLD

Current Price

$1.66

Market Cap

97.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUIG
SEER
Founded
2006
2017
Country
United States
United States
Employees
3
N/A
Industry
Finance Companies
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
114.4M
97.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
SUIG
SEER
Price
$1.21
$1.66
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$5.75
N/A
AVG Volume (30 Days)
356.7K
295.4K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
9.40
EPS
N/A
N/A
Revenue
N/A
$16,578,000.00
Revenue This Year
$49.95
$2.14
Revenue Next Year
N/A
$25.90
P/E Ratio
N/A
N/A
Revenue Growth
N/A
16.99
52 Week Low
$1.09
$1.62
52 Week High
$7.25
$2.41

Technical Indicators

Market Signals
Indicator
SUIG
SEER
Relative Strength Index (RSI) 39.65 36.93
Support Level $1.09 N/A
Resistance Level $1.53 $1.97
Average True Range (ATR) 0.09 0.05
MACD -0.01 -0.01
Stochastic Oscillator 4.55 2.63

Price Performance

Historical Comparison
SUIG
SEER

About SUIG Sui Group Holdings Limited

Sui Group Holdings Ltd operates a treasury management business. It has established a publicly traded SUI treasury, backed by an exclusive relationship with the Sui Foundation, an independent organization dedicated to the advancement and adoption of the Sui network. The company executes its business by acquiring SUI tokens through open-market purchases, institutional-grade deal flow typically reserved for cryptocurrency funds, and a negotiated purchase agreement with the Sui Foundation. It is focused on capitalizing on technology trends and ecosystem growth relating to SUI, while providing liquid and institutional-grade access to blockchains. The company has one reportable segment, which is a digital asset platform focused on maximizing SUI per share value and advancing the Sui ecosystem.

About SEER Seer Inc.

Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.

Share on Social Networks: